Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis
- PMID: 700321
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis
Abstract
Tissue cultures were performed on stools from 189 patients to detect a cytopathic toxin which is neutralized by Clostridium sordellii antitoxin. Specimens satisfying these criteria were considered positive in the tissue culture assay. Stools from 26 of 27 patients with antibiotic-associated pseudomembranous colitis were positive and 16 of these specimens showed toxin titers of 10(-3) dilutions or greater. The tissue culture assay was positive with specimens from 9 of 63 patients with antibiotic-associated diarrhea without documented pseudomembrane formation. Stools from patients with neonatal necrotizing enterocolitis, ulcerative colitis, and healthy controls were uniformly negative in this assay. Cultures were performed on stools from 38 patients with antibiotic-associated diarrhea or colitis to detect clostridia which produce a cytopathic toxin in vitro. Clostridium difficile was recovered from 6 of 8 specimens which were positive in the tissue culture assay and 5 of 30 which were negative in this assay. C. sordellii was recovered in a single specimen. One hundred and nine clostridia strains were tested in the tissue culture assay and C. difficile was the only species which produced a cytopathic toxin. All strains of this organism were positive in the tissue culture assay and, in each instance, cytotoxicity was neutralized by C. sordellii antitoxin. These results indicate that C. difficile is the major cause of antibiotic-associated pseudomembranous colitis and offer an explanation for previous studies showing that the cytotoxin of stools from these patients is neutralized by C, sordellii antitoxin.
Similar articles
-
Experimental studies of antibiotic associated colitis.Scand J Infect Dis Suppl. 1980;(Suppl 22):11-5. Scand J Infect Dis Suppl. 1980. PMID: 6937944
-
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.N Engl J Med. 1978 Mar 9;298(10):531-4. doi: 10.1056/NEJM197803092981003. N Engl J Med. 1978. PMID: 625309
-
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.Ann Biol Clin (Paris). 1989;47(2):67-70. Ann Biol Clin (Paris). 1989. PMID: 2660635 Review.
-
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.Gastroenterology. 1981 Jul;81(1):5-9. Gastroenterology. 1981. PMID: 7239125
-
How to identify the cause of antibiotic-associated diarrhea.J Crit Illn. 1994 Dec;9(12):1063-7. J Crit Illn. 1994. PMID: 10150699 Review.
Cited by
-
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections.Antibiotics (Basel). 2024 Oct 20;13(10):995. doi: 10.3390/antibiotics13100995. Antibiotics (Basel). 2024. PMID: 39452261 Free PMC article. Review.
-
Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases.J Clin Pathol. 1979 Dec;32(12):1237-43. doi: 10.1136/jcp.32.12.1237. J Clin Pathol. 1979. PMID: 536461 Free PMC article.
-
Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.Lett Appl Microbiol. 2022 Sep;75(3):526-536. doi: 10.1111/lam.13664. Epub 2022 Feb 11. Lett Appl Microbiol. 2022. PMID: 35119124 Free PMC article. Review.
-
Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study.Infect Immun. 1982 Mar;35(3):895-9. doi: 10.1128/iai.35.3.895-899.1982. Infect Immun. 1982. PMID: 7068220 Free PMC article.
-
Comparison of two commercially available enzyme immunoassays for detection of Clostridium difficile in stool specimens.J Clin Microbiol. 1994 Jan;32(1):51-3. doi: 10.1128/jcm.32.1.51-53.1994. J Clin Microbiol. 1994. PMID: 8126205 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources